Decoding metabolism, molecule by molecule.
Diseases develop years before symptoms. Genartis combines untargeted mass-spectrometry with AI to surface actionable biological insights — long before genetics or imaging can.
By the time disease shows up, biology has been changing for years.
The body's chemistry shifts long before a clinical event — but standard tools wait for the event itself.
Most panels confirm what is already advanced. The window for low-cost, preventive intervention has closed.
Genomics tells you what could happen. Metabolomics tells you what is happening, right now, inside the body.
We need actionable biological insights.
Untargeted metabolomics, decoded by AI.
Three layers working together to turn a single blood draw into early, personalized insight.
Untargeted Metabolomics
Mass spectrometry captures thousands of small molecules in blood and serum — a panoramic view of your current biology.
AI + Longitudinal Modeling
Models trained on metabolic trajectories detect subtle shifts and multi-disease risk signatures invisible to single-marker tests.
Actionable Insights
Every result is a decision — enabling early intervention, personalized care, and measurable health outcomes.
A dual revenue & impact model.
Two products, one platform. MetaScan funds growth at scale. OncoPulse delivers long-term clinical value in precision oncology.
A single blood test, AI analysis, and clear risk insights — flagging metabolic shifts before symptoms appear.
- →Corporate Wellness Programs
- →Insurance Risk Profiling
- →Fitness & Lifestyle
- →Hospitals & Preventive Clinics
Metabolomic profiling distinguishes responders from non-responders early — guiding therapy choice and trial design.
- →Breast & Colorectal Cancer (initial)
- →Responders vs Non-Responders
- →Therapy Optimization
- →Pharma & Clinical Trials
The current state of the body — not just the inherited risk.
Genomics tells a static story. Metabolomics tells a living one — shifting with diet, stress, environment, and disease, often years before any symptom appears.
Metabolic changes start years before disease.
A market in motion — toward prevention, prediction, and AI.
Diagnostics & precision medicine
Preventive + metabolic + oncology
Wellness, hospitals, insurance
Shift to preventive, early-risk care